Prognostic impact of FGFR2/3 alterations in patients with biliary tract cancers receiving systemic chemotherapy: the BITCOIN study.
暂无分享，去创建一个
M. Fassan | A. D. Dei Tos | V. Zagonel | F. Loupakis | V. Dadduzio | C. Mescoli | S. Lonardi | F. Bergamo | M. Guido | U. Cillo | E. Gringeri | C. Borga | V. Angerilli | G. Munari | J. Rearden | M. Rizzato | A. Pellino | Stefano Brignola | M. Gatti